Christopher Bowden - Chief Medical Officer at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Bowden since 11/24/2023

Holdings reported by Christopher Bowden for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 15.5K $335K $21.64 Jun 18, 2021 Direct
Stock option (right to buy) 992 Jun 18, 2021 Direct Common stock

Transactions reported by Christopher Bowden for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.